1,844 reports of this reaction
1.5% of all INSULIN ASPART reports
#11 most reported adverse reaction
WEIGHT DECREASED is the #11 most commonly reported adverse reaction for INSULIN ASPART, manufactured by Novo Nordisk. There are 1,844 FDA adverse event reports linking INSULIN ASPART to WEIGHT DECREASED. This represents approximately 1.5% of all 120,218 adverse event reports for this drug.
Patients taking INSULIN ASPART who experience weight decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT DECREASED is a less commonly reported adverse event for INSULIN ASPART, but still significant enough to appear in the safety profile.
In addition to weight decreased, the following adverse reactions have been reported for INSULIN ASPART:
The following drugs have also been linked to weight decreased in FDA adverse event reports:
WEIGHT DECREASED has been reported as an adverse event in 1,844 FDA reports for INSULIN ASPART. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT DECREASED accounts for approximately 1.5% of all adverse event reports for INSULIN ASPART, making it a notable side effect.
If you experience weight decreased while taking INSULIN ASPART, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.